EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-26461 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr19:19483400-19484250 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Nkx3-2MA0122.3chr19:19483728-19483741ATTAAGTGGATTA-6
Number of super-enhancer constituents: 8             
IDCoordinateTissue/cell
SE_09215chr19:19483114-19484967CD14
SE_14988chr19:19483154-19484492CD4_Memory_Primary_7pool
SE_21339chr19:19483111-19484446CD8_Memory_7pool
SE_23432chr19:19483389-19484372Colon_Crypt_1
SE_32412chr19:19483362-19484659Gastric
SE_40222chr19:19483245-19484320K562
SE_43282chr19:19483235-19484514Lung
SE_50929chr19:19483247-19484750Sigmoid_Colon
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr191948362919484204
Number: 1             
IDChromosomeStartEnd
GH19I019370chr191948137819484648
Enhancer Sequence
TAAACTCCTG TCCTCAAATG ATCCATCTAC CTTAGCCTCC CAAAGTGCTG GGATTACAGG 60
GGTAAGCCAC CATGTCCAGC CAATTTTTAA ATTATTTTTT GTACAGATGG AGTCTTGCTT 120
TGTTGCCCAG GCTGGTCTCA AACTCCTGGC CTCAAGCGAT CCTCCTGCCT CAGCCTCCCA 180
AATTGTTGGG GGGTTACAGG CATGAGCTAC TGTGCCTGAC CTGGAAGTGG ATTTTGAAGT 240
GGATTTTGCA GCCTGTTTGT GTCTCCCAAG CCACAAAAGA CTCTGACCTT CGTGTTTGAC 300
CAGTTCCTTG GAAGGCACCA GTCTGTGTAT TAAGTGGATT ATCCAAACCC AGACTGACTC 360
CTGGCACATG GAAGATGCTT TGGGATACAC TTATACTAAA AGGGTATTCA TTCGTGACTG 420
ATCTGAAATC CAAATCTAAT GGGGCATCCT ATATTTTCAC TTGCTAAATG TGGCCACCCT 480
AGATGCTCAA TGACATCCTT GAATAAAGGA AGCTGATGAA GTTCAAACAA ATAATTTTAC 540
CAGCGGGGTA AAAAAAGCTC AAAGCTCAGT GCACTTTGCG AAACAGTCAT TTCCTCTTCC 600
GGTCAGAATA AACTCCTGAC TCCTCCCAGG CCCAAGTGAT CAGCCACTCC CTCCTACCAG 660
CTGGCTGGGC TGCTGTGCTC AGTCCCAACT CAGGAAGGAC AAGAGTAGCT CCTGTGACCA 720
TAATGCCTGT CCACAAGCTG AGGCCCCACC CCACTCCGCC TCCTTTTCTT TTTCTTTGAA 780
ATGGAGTCTT GGTCTTTTTG CCCAGGCTAG AGTGCAGTGG CGTGATCTCG GCTCACTGCA 840
ACCTCCACCT 850